Adenocarcinoma
Showing 1 - 25 of 7,213
Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),
Recruiting
- Gastric Adenocarcinoma
- Adenocarcinoma of Gastroesophageal Junction
- Docetaxel for injection (Albumin-bound)
- Taxotere
-
Guangzhou, ChinaEthics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023
Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)
Recruiting
- Lung Adenocarcinoma Stage III
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Aug 13, 2022
Resected Pancreatic and Ampullary Adenocarcinoma at Favorable
Enrolling by invitation
- Resectable Pancreatic Adenocarcinoma
-
Milan, ItalyNational Cancer Institute of Milan
Mar 3, 2023
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for
Recruiting
- Esophageal Neoplasms
-
Ghent, Oost-Vlaanderen, BelgiumUniversity hospital Ghent
Jan 13, 2023
Clinical, Histological and Prognostic Forms of Adenocarcinoma of
Active, not recruiting
- Anal Adenocarcinoma
-
Paris, France
- +1 more
Nov 7, 2022
Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)
Not yet recruiting
- Lung Adenocarcinoma
- +3 more
- Serplulimab and Bevacizumab injection
- (no location specified)
Dec 21, 2022
Advanced Gastric Adenocarcinoma Trial in Henan (camrelizumab)
Recruiting
- Advanced Gastric Adenocarcinoma
-
Henan, ChinaHenan Tumor Hospital
Oct 13, 2022
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)
Not yet recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023
Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose
Not yet recruiting
- Neoplasm, Ovarian
- +7 more
- AVB-001 (Dose Escalation Phase)
- AVB-001 (Dose Expansion Phase)
- (no location specified)
Sep 15, 2022
Fistula-associated Anal Adenocarcinoma
Completed
- Rectal Cancer
- (no location specified)
May 14, 2022
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Avelumab and Pepinemab
- (no location specified)
Jul 14, 2022
Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Radiomics Combined With Frozen Section Prediction Model for
Not yet recruiting
- Lung Adenocarcinoma
- radiomics
- (no location specified)
Jun 22, 2022
Adenocarcinoma of the Uterine Cervix and HPV
Not yet recruiting
- Adenocarcinoma of the Uterine Cervix
- Conization and/or Hysterectomy
- (no location specified)
May 23, 2022
Treatment of Gastric Adenocarcinoma With Huachansu
Active, not recruiting
- Gastric Adenocarcinoma
-
Hefei, ChinaThe First Affiliated Hospital of Anhui Medical University
Feb 18, 2022
Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX
- Gemcitabine / Nab-paclitaxel
-
Hamilton, Ontario, CanadaJuravinski Hospital
Aug 5, 2022
Gastric Adenocarcinoma Trial in Lucknow (Observational study)
Recruiting
- Gastric Adenocarcinoma
- Observational study
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Apr 8, 2022
Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 15, 2022
Prostate Adenocarcinoma Trial in Kansas City (Osanetant)
Recruiting
- Prostate Adenocarcinoma
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023
Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- NP137
- +4 more
- (no location specified)
Sep 23, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Kashiwa (Regorafenib,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Regorafenib
- +3 more
-
Kashiwa, Chiba, JapanNational Cancer Center Hospital East
May 23, 2022
Pancreas Cancer, Gastrointestinal Adenocarcinoma Trial in New York (ultrasound)
Recruiting
- Pancreas Cancer
- Gastrointestinal Adenocarcinoma
- ultrasound
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 12, 2022
Klotho _ LRP-6 _ Gastric Adenocarcinoma
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Prognostic study
- (no location specified)
Jun 6, 2022